Articles from May 2009 ↓

 

novel tetracycline from Warner Chilcott and Paratek

Some very preliminary internet crumbs about a new possible rosacea treatment under development. The treatment under development is listed as a “novel tetracycline”. Warner Chilcott Limited calls itself a “specialty pharmaceutical company, that engages in the development, manufacture, marketing, and sale of branded prescription pharmaceutical products in women’s healthcare and dermatology segments primarily in the United States”. In the WCRX 2007 Annual …

 

Botox for neural symptoms and flushing, user reviews

Some interesting discussions from both experts and users of botox treatments for rosacea have are emerging online and are worth reviewing.

A quick search on Google shows that several clinics are now offering botox as part of their rosacea treatments. Better known for it’s cosmetic use, the highly toxic protein known as C. botulinum, Botox shows promise as an adjunctive treatment for …

 

Glyco Mira developing anti-cathelicidin treatment ?

A brief paragraph in a recent article in The Salt Lake Tribune looks quite interesting. A company called Glyco Mira (seemingly a company without a web site) is developing a drug that “may be able to cure the underlying problem that causes rosacea”. A pretty tall prediction for sure. So what are they talking about ? Glyco Mira have licensed and anti-inflammatory drug from the …